Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma (vol 16, 106, 2017)

被引：2
|
作者：
Liu, Aibin [1 ,2 ]
Zhu, Jinrong [1 ]
Wu, Geyan [1 ]
Cao, Lixue [1 ]
Tan, Zhanyao [1 ]
Zhang, Shuxia [1 ]
Jiang, Lili [3 ]
Wu, Jueheng [4 ]
Li, Mengfeng [4 ]
Song, Libing [2 ]
Li, Jun [1 ]
机构：
[1] Sun Yat Sen Univ, Zhongshan Sch Med, Affiliated Guangzhou Women & Childrens Hosp, Program Canc Res,Dept Biochem, 74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, Dept Expt Res, State Key Lab Oncol Southern China, Guangzhou 510060, Peoples R China
[3] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Sch Basic Med Sci, Key Lab Prot Modificat & Degradat, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou, Peoples R China
来源：
MOLECULAR CANCER | 2021年 / 20卷 / 01期
关键词：
D O I：
10.1186/s12943-021-01425-4
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma
    Liu, Aibin
    Zhu, Jinrong
    Wu, Geyan
    Cao, Lixue
    Tan, Zhanyao
    Zhang, Shuxia
    Jiang, Lili
    Wu, Jueheng
    Li, Mengfeng
    Song, Libing
    Li, Jun
    MOLECULAR CANCER, 2017, 16
  • [2] Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma
    Aibin Liu
    Jinrong Zhu
    Geyan Wu
    Lixue Cao
    Zhanyao Tan
    Shuxia Zhang
    Lili Jiang
    Jueheng Wu
    Mengfeng Li
    Libing Song
    Jun Li
    Molecular Cancer, 16
  • [3] Correction to: Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma
    Aibin Liu
    Jinrong Zhu
    Geyan Wu
    Lixue Cao
    Zhanyao Tan
    Shuxia Zhang
    Lili Jiang
    Jueheng Wu
    Mengfeng Li
    Libing Song
    Jun Li
    Molecular Cancer, 20
  • [4] MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F
    Yang, H.
    Wei, Y. -N.
    Zhou, J.
    Hao, T. -T.
    Liu, X. -L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (14) : 3200 - 3206
  • [5] LncRNA XIST Inhibits the Progression of Oral Squamous Cell Carcinoma via Sponging miR-455-3p/BTG2 Axis
    Li, Qingbin
    Sun, Qiang
    Zhu, Baoyu
    ONCOTARGETS AND THERAPY, 2020, 13 : 11211 - 11220
  • [6] LINC00472 suppresses oral squamous cell carcinoma growth by targeting miR-455-3p/ELF3 axis
    Liu, Xiu
    Ma, Xinrong
    Li, Hongyu
    Wang, Yu
    Mao, Minghui
    Liang, Chao
    Hu, Ying
    BIOENGINEERED, 2022, 13 (01) : 1162 - 1173
  • [7] MiR-455-3p inhibits the degenerate process of chondrogenic differentiation through modification of DNA methylation
    Hao Sun
    Xiaoyi Zhao
    Chengyun Zhang
    Ziji Zhang
    Jiayong Lun
    Weiming Liao
    Zhiqi Zhang
    Cell Death & Disease, 9
  • [8] MiR-455-3p inhibits the degenerate process of chondrogenic differentiation through modification of DNA methylation
    Sun, Hao
    Zhao, Xiaoyi
    Zhang, Chengyun
    Zhang, Ziji
    Lun, Jiayong
    Liao, Weiming
    Zhang, Zhiqi
    CELL DEATH & DISEASE, 2018, 9
  • [9] miR-455-3p functions as a tumor suppressor in colorectal cancer and inhibits cell proliferation by targeting TPT1
    Sun, Yuanyuan
    Wang, Yan
    Yang, Hainan
    Xu, Yan
    Yu, Haipeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (05): : 2522 - 2529
  • [10] MiR-455-3p regulates glioma cell proliferation by targeting PAX6
    Han, Jizhong
    Xiong, Yu
    Deng, Huajiang
    Zhou, Jie
    Peng, Lilei
    Xiang, Wei
    Ming, Yang
    Chen, Ligang
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (04) : 689 - 695
12345